Trastuzumab Withdrawn Phase 3 Trials for Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00053339Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer